None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 19 to 64 years old 2. Individuals who have received sufficient explanation about the purpose, content, and clinical research equipment of the trial prior to participation, have voluntarily decided to participate in the clinical research, and have provided written consent 3. Individuals who can be followed up during the trial period
Exclusion criteria
Exclusion criteria: 1. Patients with sleep disorders (somnambulism, abnormal behavior during sleep, etc.) 2. Those who are currently taking medication for psychiatric disorders other than insomnia within the last three months 3. Pregnant women and nursing mothers 4. Others deemed unsuitable for the test by the examiner 5. Those diagnosed with circadian rhythm sleep disorders 6. Shift workers 7. Individuals who regularly take sleeping pills or sleep-inducing drugs 8. Individuals with skin allergies or abnormal reactions to sunlight 9. Individuals taking photosensitive drugs 10. Individuals with severe visual impairment, severe hearing impairment, or communication disorders that prevent them from undergoing intervention and efficacy evaluation 11. Individuals who have participated in other clinical studies involving intervention methods within 30 days of study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Leeds Sleep Evaluation Questionnaire(LSEQ) | — |
Secondary
| Measure | Time frame |
|---|---|
| General Sleep Disturbance Scale(GSDS);Pittsburgh Sleep Quality Index(PSQI);adverse events | — |
Countries
Korea, Republic of
Contacts
Cheonan Korean Medicine Hospital of Daejeon University